Langermann Sol 4
4 · NextCure, Inc. · Filed Feb 2, 2022
Insider Transaction Report
Form 4
NextCure, Inc.NXTC
Langermann Sol
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2022-01-31+117,400→ 117,400 totalExercise: $5.57Exp: 2032-01-30→ Common Stock (117,400 underlying)
Footnotes (1)
- [F1]One fourth of the option vests on January 31, 2023. The remainder vests in 36 monthly installments beginning on February 28, 2023.